FDA Inspection
Intas Pharmaceuticals LimitedIntas Pharmaceuticals Limited – FDA Inspection, Jun 19, 2017
Record Details
This FDA Inspection record concerns Intas Pharmaceuticals Limited, with an inspection on June 19, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 238313c0-72c9-4569-810f-9034623241ce
Inspection Facts
- Inspection number
- 1014641
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.166(a)(1)Sample size - test intervals
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Intas Pharmaceuticals Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| December 2, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 28, 2019 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| October 19, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 19, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Intas Pharmaceuticals Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.